These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 7465532

  • 1. [Treatment of small-cell bronchogenic carcinoma with a combination of chemotherapy and irradiation (author's transl)].
    Dundalek E.
    Prax Klin Pneumol; 1980 Dec; 34(12):719-23. PubMed ID: 7465532
    [No Abstract] [Full Text] [Related]

  • 2. [Chemotherapy in bronchogenic carcinoma (author's transl)].
    Bruntsch U.
    Rontgenblatter; 1977 Apr; 30(4):196-201. PubMed ID: 67629
    [Abstract] [Full Text] [Related]

  • 3. [Prognostic factors in the chemotherapy of bronchial cancers].
    Alberto P.
    Schweiz Med Wochenschr; 1974 Feb 23; 104(8):268-71. PubMed ID: 4360755
    [No Abstract] [Full Text] [Related]

  • 4. Chemotherapy in bronchogenic carcinoma.
    Ojala A, Nikkanen VN, Palojoki A, Paloheimo S.
    Ann Clin Res; 1977 Feb 23; 9(1):12-4. PubMed ID: 329741
    [Abstract] [Full Text] [Related]

  • 5. [Polychemotherapy of inoperable bronchogenic carcinoma: preliminary results (author's transl)].
    Schulz V, Busch S, Endres P, Rubin R, Schönen M.
    Prax Klin Pneumol; 1979 Apr 23; 33 Suppl 1():660-1. PubMed ID: 88732
    [Abstract] [Full Text] [Related]

  • 6. [Cancer chemotherapy of inoperable bronchial carcinomas (author's transl)].
    Rieche K.
    Z Erkr Atmungsorgane; 1975 Feb 23; 142(2):140-8. PubMed ID: 179223
    [Abstract] [Full Text] [Related]

  • 7. Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinoma.
    Bitran JD, Desser RK, DeMeester T, Shapiro CM, Billings A, Rubenstein L, Evans R, Colman M, Rao CY, Griem M, Golomb HM.
    Cancer Treat Rep; 1978 Mar 23; 62(3):327-32. PubMed ID: 348305
    [Abstract] [Full Text] [Related]

  • 8. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP) treatment of non-oat cell bronchogenic carcinoma.
    Vogelzang NJ, Bonomi PD, Rossof AH, Wolter J.
    Cancer Treat Rep; 1978 Oct 23; 62(10):1595-7. PubMed ID: 709563
    [No Abstract] [Full Text] [Related]

  • 9. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.
    Bitran JD, Desser RK, DeMeester TR, Colman M, Evans R, Billings A, Griem M, Rubenstein L, Shapiro C, Golomb HM.
    Cancer Treat Rep; 1976 Sep 23; 60(9):1225-30. PubMed ID: 189920
    [Abstract] [Full Text] [Related]

  • 10. Chemo-immunotherapy for unresectable bronchogenic carcinoma.
    Sarna GP, Lowitz BB, Haskell CM, Dorey FJ, Cline MJ.
    Cancer Treat Rep; 1978 May 23; 62(5):681-7. PubMed ID: 350397
    [Abstract] [Full Text] [Related]

  • 11. The role of chemotherapy in the treatment of lung cancer.
    Selawry OS.
    Semin Oncol; 1974 Sep 23; 1(3):259-72. PubMed ID: 4143488
    [No Abstract] [Full Text] [Related]

  • 12. [Chemotherapy-cum-radiotherapy-cum-surgery in the treatment of small-cell bronchogenic carcinoma (author's transl)].
    Gatzemeier U.
    Prax Klin Pneumol; 1980 Feb 23; 34(2):102-7. PubMed ID: 7378158
    [No Abstract] [Full Text] [Related]

  • 13. Combination chemotherapy for non-small cell bronchogenic carcinoma with bleomycin, doxorubicin, methotrexate, and cis-dichlorodiammineplatinum(II) (BAMP).
    Vogl SE, Wollner D, Kaplan BH, Berenzweig M.
    Cancer Treat Rep; 1980 Feb 23; 64(4-5):717-9. PubMed ID: 6159081
    [No Abstract] [Full Text] [Related]

  • 14. Relationship between myelosuppression and chemotherapeutic response in small cell bronchogenic carcinoma.
    Holoye PY.
    Exp Hematol; 1985 Feb 23; 13 Suppl 16():72-9. PubMed ID: 2985416
    [Abstract] [Full Text] [Related]

  • 15. Six-drug combination chemotherapy for nonresectable bronchogenic carcinoma.
    Miller CF, Weltz MD, Heim WJ, Blom J.
    Cancer Treat Rep; 1979 Aug 23; 63(8):1351-3. PubMed ID: 113094
    [No Abstract] [Full Text] [Related]

  • 16. [Combination chemotherapy in patients with disseminated bronchogenic carcinoma (author's transl)].
    Gropp C, Havemann K, Gassel WD, Hess F, Prignitz R, Schmidt M, Sodomann CP.
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1977 Dec 15; 90(3):301-6. PubMed ID: 146331
    [Abstract] [Full Text] [Related]

  • 17. [The role of chemotherapy in the palliative and curative treatment of lung cancer (author's transl)].
    Kenis Y, Rozencweig M.
    Acta Tuberc Pneumol Belg; 1975 Dec 15; 66(4-5):368-79. PubMed ID: 178163
    [No Abstract] [Full Text] [Related]

  • 18. [VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].
    Ryssel HJ, Hasler E, Sonntag RW, Cavalli F, Martin J, Tschopp L, Brunner KW.
    Schweiz Med Wochenschr; 1977 Jul 02; 107(26):912-5. PubMed ID: 877537
    [Abstract] [Full Text] [Related]

  • 19. Combination chemotherapy of bronchogenic carcinoma. I. Non-oat cell.
    Livingston RB.
    Cancer Treat Rev; 1977 Sep 02; 4(3):153-65. PubMed ID: 73419
    [No Abstract] [Full Text] [Related]

  • 20. Chemotherapy for small cell bronchogenic carcinoma: CCNU and doxorubicin compared to CCNU, doxorubicin, vincristine, and procarbazine.
    Vogelzang NJ, Trowbridge RC, Frenning DH, Theologides A, Kennedy BJ, Kelly DR, Ewing SL, Vosika GJ.
    Cancer Treat Rep; 1980 Sep 02; 64(8-9):997-1000. PubMed ID: 6256076
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.